Literature DB >> 1427370

Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein.

J F Colombel1, G Torpier, A Janin, O Klein, A Cortot, M Capron.   

Abstract

The eosinophil population is increased in the jejunal mucosa of patients with coeliac disease. Eosinophils may participate in the mucosal damage by releasing their granule components that have cytotoxic properties such as eosinophil cationic protein (ECP) and major basic protein (MBP). This study aimed to assess the presence of ECP and MBP in the jejunal mucosa of 10 adult patients with active coeliac disease who presented with villous flattening. Endoscopic jejunal biopsy specimens were obtained from macroscopically flattened jejunal mucosa and were processed for ultrastructural study and immunogold labelling using anti-MBP, anti-ECP, and anti-IgA antibodies. Numerous eosinophils were found in the upper part of the lamina propria and showed two types of morphological change: some were lytic and others exhibited ultrastructural signs of activation, containing altered granules with fading of the central core. IgA plasma cells were intermingled with eosinophils and had dense deposits on the external side of their cytoplasmic membrane. MBP was detected in central cores of granules but also diffusely in their matrix and in tight association with dense extracellular deposits. Conversely, ECP was detected only in the matrix of eosinophil granules. This study showed that numerous eosinophils are in an activated state in the mucosa of patients with active coeliac disease and release cytotoxic proteins such as MBP, which could contribute to the mucosal damage. The observation that eosinophils and IgA plasmocytes were closely associated in the mucosa supports a role for IgA in eosinophil recruitment and activation in coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427370      PMCID: PMC1379484          DOI: 10.1136/gut.33.9.1190

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  Immunoglobulin secretion by isolated intestinal lymphocytes: spontaneous production and T-cell regulation in normal small intestine and in patients with coeliac disease.

Authors:  J E Crabtree; R V Heatley; M L Losowsky
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

2.  Enhancement of structural preservation and immunocytochemical staining in low temperature embedded pancreatic tissue.

Authors:  J Roth; M Bendayan; E Carlemalm; W Villiger; M Garavito
Journal:  J Histochem Cytochem       Date:  1981-05       Impact factor: 2.479

3.  Eosinophil- and eosinophil granule-mediated pneumocyte injury.

Authors:  G H Ayars; L C Altman; G J Gleich; D A Loegering; C B Baker
Journal:  J Allergy Clin Immunol       Date:  1985-10       Impact factor: 10.793

4.  Jejunal plasma cells and in vitro immunoglobulin production in adult coeliac disease.

Authors:  G M Wood; P D Howdle; L K Trejdosiewicz; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

5.  IgA-induced eosinophil degranulation.

Authors:  R I Abu-Ghazaleh; T Fujisawa; J Mestecky; R A Kyle; G J Gleich
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

6.  Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.

Authors:  G Torpier; J F Colombel; C Mathieu-Chandelier; M Capron; J P Dessaint; A Cortot; J C Paris; A Capron
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

7.  Purification of human eosinophil-derived neurotoxin.

Authors:  D T Durack; S J Ackerman; D A Loegering; G J Gleich
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

8.  Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor gamma/delta heterodimer in human intestinal intraepithelial lymphocytes.

Authors:  J Spencer; P G Isaacson; T C Diss; T T MacDonald
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

9.  The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni.

Authors:  J B Taylor; A Vidal; G Torpier; D J Meyer; C Roitsch; J M Balloul; C Southan; P Sondermeyer; S Pemble; J P Lecocq
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

10.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Authors:  Y Yamaguchi; Y Hayashi; Y Sugama; Y Miura; T Kasahara; S Kitamura; M Torisu; S Mita; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  12 in total

1.  Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts.

Authors:  G T Furuta; S J Ackerman; J Varga; A M Spiess; M Y Wang; B K Wershil
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells.

Authors:  V De Re; M P Simula; L Caggiari; N Orzes; M Spina; A Da ponte; L De Appollonia; R Dolcetti; V Canzonieri; R Cannizzaro
Journal:  Clin Exp Immunol       Date:  2007-03-05       Impact factor: 4.330

Review 3.  Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections.

Authors:  Pooja Mehta; Glenn T Furuta
Journal:  Immunol Allergy Clin North Am       Date:  2015-06-17       Impact factor: 3.479

4.  Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

Authors:  S Dubucquoi; A Janin; O Klein; P Desreumaux; P Quandalle; A Cortot; M Capron; J F Colombel
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

5.  Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.

Authors:  B Wallaert; P Desreumaux; M C Copin; I Tillie; A Benard; J F Colombel; B Gosselin; A B Tonnel; A Janin
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

6.  Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis.

Authors:  P Desreumaux; A Janin; E Delaporte; S Dubucquoi; F Piette; A Cortot; M Capron; J F Colombel
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

7.  Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia.

Authors:  Craig A Friesen; Zhiyue Lin; Meenal Singh; Vivekanand Singh; Jennifer V Schurman; Nanci Burchell; Jose T Cocjin; Richard W McCallum
Journal:  Dig Dis Sci       Date:  2008-03-05       Impact factor: 3.199

Review 8.  Intestinal eosinophils, homeostasis and response to bacterial intrusion.

Authors:  Alessandra Gurtner; Ignacio Gonzalez-Perez; Isabelle C Arnold
Journal:  Semin Immunopathol       Date:  2021-04-30       Impact factor: 9.623

9.  Synergism between prior Anisakis simplex infections and intake of NSAIDs, on the risk of upper digestive bleeding: a case-control study.

Authors:  Florencio M Ubeira; Ana M Anadón; Angel Salgado; Alfonso Carvajal; Sara Ortega; Carmelo Aguirre; María José López-Goikoetxea; Luisa Ibanez; Adolfo Figueiras
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

Review 10.  Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder.

Authors:  Margaret R Dunne; Greg Byrne; Fernando G Chirdo; Conleth Feighery
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.